INTRODUCTION
============

One of the principal characteristics of neuronal differentiation is the induction of membrane protrusions that develop into neurites, which in turn become discernible as axons and dendrites as the neuron becomes polarized ([@B2]). Vesicular trafficking serves as a major mechanism for supplying membrane components to rapidly growing neurite tips and delivers surface receptors, including the Trk family of receptor tyrosine kinases that mediate the effects of neurotrophins on neuronal development and survival ([@B10]; [@B48]; [@B75]; [@B60]). Trk receptors synthesized at the soma are targeted to the neurite tips by anterograde transport and initiate neurotrophin (ligand)- dependent downstream signaling, which triggers neurite outgrowth ([@B40]; [@B14]). On ligand binding, Trk receptors are internalized to a series of endosomes via retrograde transport; some populations of receptors are targeted to lysosomes for degradation, whereas others are recycled back to the cell surface. The importance of vesicular trafficking in Trk signaling is further reinforced by the finding that receptor-mediated signaling can occur in endosomes after receptor internalization ([@B5]; [@B63]; [@B83]). Thus, elucidating the molecular mechanisms underlying Trk receptor targeting is of crucial importance for understanding neurotrophin-mediated signaling.

The acidic luminal pH milieus of organelles along both anterograde and retrograde trafficking pathways are tightly regulated, and progressive acidification along these pathways is required for correct sorting and routing of endosomal cargoes ([@B61]; [@B70]; [@B6]). Although it is generally accepted that the vacuolar-type H^+^-ATPase proton pump (V-ATPase) plays a pivotal role in organellar acidification by pumping protons into lumens ([@B27]; [@B56]), establishment of the distinct pH environments in different endosomal fractions cannot be explained solely by V-ATPase activity, and the participation of other proton-translocating mechanisms such as organellar ion transporters and channels is essential to establish and maintain the distinct organellar pH milieus ([@B13]; [@B78]). Neurons contain a more sophisticated endosomal system, which permits neuron-specific targeting and signaling ([@B101]; [@B49]). Given the importance of endosomal pH in vesicular trafficking, it is likely that a diverse array of proton transport mechanisms govern endosomal pH homeostasis in neurons. Of particular interest in this regard is NHE5, a unique member of the Na^+^/H^+^ exchanger family abundantly expressed in neuron-rich regions of brain ([@B4]; [@B7]). We showed previously that *N*-methyl-[d]{.smallcaps}-aspartate receptor activation leads to recruitment of NHE5 to the cell surface at the synapse, where it regulates activity-dependent local pH changes and dendritic spine growth ([@B22]). At steady state, NHE5 is largely associated with endosomes ([@B54]), predominantly recycling endosomes ([@B89]). However, the functional significance of NHE5 in the recycling endosome, a key organelle that regulates multiple vesicular trafficking pathways ([@B59]; [@B33]; [@B39]; [@B41]; [@B92]), is an open question. Rat pheochromocytoma PC12 cells express the TrkA receptor tyrosine kinase and extend neurites upon nerve growth factor (NGF) stimulation, serving as an excellent model in which to study neurotrophin-mediated signal transduction pathways and vesicular trafficking ([@B34]; [@B97]; [@B57]; [@B36]; [@B37]). Here we show that NHE5 potently acidifies recycling endosomal pH, regulates TrkA receptor cell-surface abundance, and promotes neurite outgrowth in PC12 cells treated with NGF.

RESULTS
=======

NHE5 is functional in recycling endosomes
-----------------------------------------

We previously reported that NHE1 and NHE5 are the two major NHEs expressed in PC12 cells and generated short hairpin RNA (shRNA) PC12 cell lines that have constitutively reduced expression of these proteins ([@B22]). Using cell-surface biotinylation and Western blot, we observed that little NHE5 is present on the plasma membrane, whereas NHE1 and transferrin receptor (TfnR) are abundantly expressed on the plasma membrane of resting PC12 cells ([Figure 1A](#F1){ref-type="fig"}). Actin was not detectable on the cell surface, indicating that membrane integrity was retained during these experiments. To test for NHE5 activity on the cell surface, we loaded PC12 cells with the pH-sensitive fluorescent dye 2′-7′-bis(carboxyethyl)-5(6)-carboxyfluorescein (BCECF) and monitored the recovery of cytosolic pH (pH*~i~*) from an imposed intracellular acid load using the ammonium prepulse technique ([Figure 1B](#F1){ref-type="fig"}). After washout of ammonium with Na^+^-free buffer, pH*~i~* failed to recover from the internal acid load and remained acidic until the reintroduction of external Na^+^, at which time it rapidly recovered to normal values. The specific NHE1 inhibitor cariporide (10 μM; [@B58]) completely prevented the recovery of pH*~i~* observed after the reintroduction of external Na^+^ and, in agreement with previous work ([@B88]), 10 μM cariporide failed to inhibit NHE5 activity heterologously expressed in NHE-deficient Chinese hamster ovary mutant AP-1 cells (Supplemental Figure S1). These findings indicate that NHE1, but not NHE5, is the major functional NHE on the plasma membrane in PC12 cells.

![NHE5 is not functional on the plasma membrane in resting PC12 cells. (A) PC12 cells were treated with a cell-surface biotinylating agent. Biotinylated cell-surface proteins were purified by affinity trap with NeutrAvidin beads. Total lysate (Lysate) and biotinylated proteins eluted from the beads (Surface) were resolved in SDS--PAGE and immunoblotted with the indicated antibodies. Lysate protein fractions represent 10% of the protein loaded in the surface fraction. (B) Cells loaded with BCECF were subjected to cytosolic acidification by briefly exposing cells to NH~4~Cl followed by washout with NaCl-free solution. NHE activity was induced by reintroducing the Na^+^-containing solution in the absence or presence of the NHE1-specific inhibitor cariporide (10 μM). No recovery from the internal acid load was observed in the presence of cariporide, indicating that NHE1 is the only functional NHE on the plasma membrane in PC12 cells. Records represent pH*~i~* measurements obtained simultaneously from 40 control and 34 cariporide-treated cells and are representative of three independent experiments under each condition.](3435fig1){#F1}

Previous studies showed that NHE5 is largely associated with recycling endosomes under steady-state conditions ([@B89], [@B87]; [@B21]). We next tested the possible involvement of NHE5 in recycling endosomal pH regulation. Control PC12 cells or PC12 cells stably expressing NHE5-shRNAs (described in [@B22]) were incubated with a mixture of two types of transferrin (Tfn), one conjugated with the pH-sensitive fluorescent dye fluorescein and the other conjugated with the pH-insensitive dye Alexa Fluor 568, to generate a ratiometric reporter of recycling endosomal pH. Cells were rinsed three times with prewarmed serum-free media and transferred to the preheated (37°C) stage of a confocal microscope, and 15 min later, image capture began for fluorescein/Alexa Fluor 568 emission intensity ratio measurements. Under these conditions, Tfn was observed mainly in perinuclear structures ([Figure 2B](#F2){ref-type="fig"}), a distribution typical of recycling endosomes ([Figure 2C](#F2){ref-type="fig"}). The fluorescence ratios collected from live-cell imaging were calibrated to endosomal pH using the high--\[K^+^\]/nigericin technique ([@B70]; [@B25]; [@B82]; [@B12]; [@B66]). In control PC12 cells, recycling endosomal pH was 6.20 ± 0.02 (SEM), whereas in shNHE5 cells recycling endosomal pH was 6.48 ± 0.02, a value significantly more alkaline than in parental PC12 cells ([Figure 2A](#F2){ref-type="fig"}). After 5-min treatment with the V-ATPase inhibitor bafilomycin, we observed endosomal alkalinization to pH 6.52 ± 0.02 in control PC12 cells and 6.75 ± 0.03 in shNHE5 cells ([Figure 2A](#F2){ref-type="fig"}). These results suggest that NHE5 is a potent recycling endosomal acidifier, playing an equally important role as the V-ATPase in PC12 cells. We next addressed the effect of NHE5 knockdown on early endosomal pH using a previously described protocol with some modifications ([@B30]). As shown in Supplemental Figure S2, there was no significant difference in early endosomal pH between the two cell lines (pH = 6.06 ± 0.02 in PC12 cells vs. 6.01 ± 0.02 in shNHE5 cells).

![NHE5 is potent acidifier of recycling endosomes. (A) Endosomal pH in control PC12 cells and shNHE5 cells in the presence or absence of bafilomycin treatment. A mixture of fluorescein-conjugated (pH-sensitive) and Alexa Fluor 568--conjugated (pH-insensitive) transferrin was used as a ratiometric recycling endosomal pH reporter. *N* = 100--200 cells per condition. Error bars represent SEM, \*\**p* \< 0.01 (Student\'s *t* test). (B) A set of representative live-cell images used for pH measurement experiments. Fluorescence signals for transferrin associated with perinuclear structures (arrowheads) were captured under live-cell confocal imaging and analyzed for pH determination (see *Materials and Methods*). Scale bar, 10 μm. (C) Double immunofluorescence labeling of transferrin and endosomal markers. PC12 cells were treated with Alexa Fluor 568--conjugated transferrin and subjected to chase incubation under the same condition as in A and B. Rab11 antibody, heterologously expressed mCherry-tagged Rab5, and mCherry-tagged Rab7 were used to visualize recycling and early and late endosomes, respectively. Scale bars, 10 μm.](3435fig2){#F2}

NHE5 participates in TrkA trafficking
-------------------------------------

NGF-induced differentiation in PC12 cells involves NGF signaling through the high-affinity receptor tyrosine kinase TrkA and the low-affinity p75 receptor ([@B40]; [@B97]; [@B14]). TrkA traffics between the cell surface and the recycling endosomal compartment, and this recycling controls the steady-state surface abundance and activity of TrkA ([@B1]; [@B3]; [@B93]). Consistent with this, we found that TrkA exhibits some association with the recycling endosomal marker Rab11 at the perinuclear region and, to a lesser extent, the early endosomal marker EEA1 ([Figure 3A](#F3){ref-type="fig"}, PC12). Reduced NHE5 expression did not disrupt the endosomal association of TrkA ([Figure 3A](#F3){ref-type="fig"}, shNHE5). Because NHE5 is predominantly associated with endosomal compartments in hippocampal neurons in primary culture ([@B22]), we addressed whether NHE5 and TrkA associate in endosomes of PC12 cells. NHE5 and TrkA exhibited close association mostly in intracellular compartments ([Figure 3B](#F3){ref-type="fig"}). To test the potential involvement of NHE5 in TrkA trafficking behavior, we next examined the total and cell-surface abundance of TrkA by surface biotinylation and Western blot. There was no difference in the total abundance of TrkA between control cells and PC12 cells stably expressing shNHE5 or shNHE1 ([Figure 4, A and C](#F4){ref-type="fig"}), suggesting that reduced expression of NHE5 or NHE1 has little effect on TrkA degradation or synthesis. In contrast, the cell-surface abundance of TrkA was significantly reduced in cells expressing shRNA for NHE5 (shNHE5; by approximately half) compared with control PC12 cells or PC12 cells expressing shRNA for NHE1 (shNHE1; [Figure 4, A and D](#F4){ref-type="fig"}). When cell lysates were not incubated with the biotinylating agent, TrkA was not detected ([Figure 4B](#F4){ref-type="fig"}). Similar levels of cell-surface populations of Na^+^/K^+^ ATPase pump α-subunit and TfnR across the cell lines were observed ([Figure 4, A and E](#F4){ref-type="fig"}), suggesting the specific effects of NHE5 on TrkA trafficking. After NGF treatment, there was a time-dependent reduction in cell-surface TrkA abundance in control PC12 cells ([Figure 4, F and G](#F4){ref-type="fig"}), as reported previously ([@B35]; [@B45]; [@B47]; [@B15]). To test the potential involvement of NHE5 in NGF-induced TrkA internalization, shRNA-expressing cells were treated with NGF for the indicated times, and TrkA retained on the cell surface was detected by biotinylation (see *Materials and Methods*). Although the initial cell-surface abundance of TrkA is significantly lower in shNHE5 cells than in shNHE1 or control cells (time 0, [Figure 4F](#F4){ref-type="fig"}), densitometric analysis showed that the rates of NGF-induced TrkA endocytosis were comparable among the three cell lines ([Figure 4G](#F4){ref-type="fig"}). These results suggest that knockdown of NHE5 but not NHE1 reduces steady-state TrkA abundance on the cell surface but not overall TrkA protein levels or rates of endocytosis. To test whether TrkA trafficking from recycling endosomes to the plasma membrane is affected by NHE5 knockdown, we next determined recycling rates of biotinylated TrkA from endosomes to the plasma membrane. As shown in [Figure 4, H and I](#F4){ref-type="fig"}, a slight but significant delay in recycling rates was detected in shNHE5 cells.

![Intracellular localization of TrkA and NHE5. (A) Double immunofluorescence microscopy of TrkA (green) and EEA1 (red) or Rab11 (red) in PC12 control cells (PC12) and PC12 cells stably expressing shRNA for NHE5 (shNHE5). Fixed cells were treated with rabbit polyclonal anti-TrkA antibody and mouse monoclonal anti-EEA1 antibody or anti-Rab11 antibody. Alexa Fluor 488--conjugated goat anti-mouse and Alexa Fluor 568--conjugated goat anti-rabbit antibodies were used to visualize the signals. (B) Double immunofluorescence microscopy of NHE5 (green) and TrkA (red) in PC12 cells. Fixed cells were treated with rabbit polyclonal anti-NHE5 antibody and mouse monoclonal anti-TrkA antibody to visualize the endogenous protein localization. Scale bars, 10 μm.](3435fig3){#F3}

![NHE5 knockdown affects TrkA steady-state surface abundance but not NGF-induced internalization. (A--E) Control PC12 cells (PC12) and PC12 cells stably expressing shRNAs against NHE5 (shNHE5) or NHE1 (shNHE1) were incubated with a cell-surface biotinylation reagent, and total and cell-surface TrkA, NKA, or TfnR were detected by Western blot. Western blot shown in A is representative of three independent experiments. (B) No-biotin control confirmed that there was no fraction being pulled down nonspecifically. The intensity of the bands was determined by densitometry, and the data represent the mean ± SEM of relative levels of total TrkA (C), cell-surface TrkA (D), and TfnR (E) of at least three experiments. \*\**p* \< 0.01 (paired Student\'s *t* test compared with control). (F, G) Cells were serum starved overnight and then treated with 50 ng/ml NGF as indicated, and the total and cell-surface abundance of TrkA, as well as of TfnR, at each time point were determined. Western blots shown are representative of three independent experiments. (G) Relative NGF-induced TrkA endocytosis was measured by quantifying the TrkA cell-surface abundance at various times after NGF treatment. The rate of TrkA endocytosis was not different between the cell lines tested. Error bars represent SEM. (H, I) After surface biotinylation, cells were incubated for 60 min at 37°C. Biotin remaining on cell-surface proteins was removed by glutathione, and then cells were subjected to the second incubation with NGF (50 ng/ml) at 37°C for 0, 15, or 30 min and treated with glutathione to remove biotin from the proteins recycled back to the plasma membrane, and relative TrkA abundance was determined. For pull down, 130 and 400 μg of total protein were used for PC12 and shNHE5 cells, respectively. The densitometry data of relative levels of total TrkA are presented with mean ± SEM. \**p* \< 0.05 (paired Student\'s *t* test, *n* = 6 experiments).](3435fig4){#F4}

Organelle alkalinization redistributes TrkA
-------------------------------------------

Our data are consistent with the possibility that NHE5 may be a novel regulator of recycling endosomal pH to influence the trafficking of TrkA between endosomes and the plasma membrane. To further test this hypothesis, we examined the effect of bafilomycin on TrkA cell-surface abundance. Treatment of control PC12 cells with bafilomycin (250 nM) caused a significant decrease in TrkA surface abundance after 5--6 h of bafilomycin treatment but not in total TrkA protein expression ([Figure 5, A and B](#F5){ref-type="fig"}). The cell-surface abundance of TfnR, another recycling receptor, was not noticeably affected by bafilomycin. Bafilomycin treatment, which is known to lead to organellar alkalinization, resulted in the accumulation of TrkA inside the cell similar to that observed in cells with stable knockdown of NHE5. Taken together, these results suggest that steady-state trafficking of TrkA through recycling endosomes is sensitive to endosomal pH.

![Bafilomycin treatment reduces TrkA surface levels. (A) Serum-starved PC12 cells were incubated with bafilomycin A1 (250 nM) for the times indicated, and cell-surface TrkA or TfnR was detected by surface biotinylation assay. (B) TrkA or TfnR cell-surface abundance was determined by densitometry, and relative intensities were calculated. *N* = 3; error bars represent SEM; \*\**p* \< 0.01 (Student\'s *t* test) for difference from untreated cells (time 0).](3435fig5){#F5}

NHE5 knockdown affects NGF signaling
------------------------------------

Because NHE5 knockdown affects TrkA trafficking and its cellular distribution, we reasoned that NHE5 might modulate TrkA downstream signaling. Control PC12 or shNHE5 cells were treated with 50 ng/ml NGF for 0--60 min, and the phosphorylation status of Akt (also known as PKB) and ERK1/2, two major downstream kinases, were evaluated by Western blot using antibodies that specifically recognize phosphorylated Akt and Erk1/2, respectively. NGF treatment of serum-starved PC12 cells caused a clear increase in the phosphorylation levels of Akt and Erk1/2 within 5 min. In contrast, phosphorylated Akt in response to NGF was significantly suppressed in shNHE5 cells under the same experimental conditions ([Figure 6, A and C](#F6){ref-type="fig"}). Erk1/2 phosphorylation in shNHE5 cells was reduced at the 5-min time point, reaching ∼30% of that observed in control cells, and then formed a slightly delayed peak at the 10-min time point ([Figure 6, B and D](#F6){ref-type="fig"}). Of interest, although shNHE1 cells showed weaker and delayed Akt phosphorylation in response to NGF treatment, Erk1/2 phosphorylation was not affected. To examine the role of endosomal alkalinization in NGF-TrkA signaling, we treated PC12 cells with bafilomycin for 6 h, a condition that significantly reduced cell-surface TrkA levels ([Figure 5, A and B](#F5){ref-type="fig"}), and assessed its effect on NGF-induced phosphorylation of Akt and Erk1/2. Bafilomycin treatment markedly decreased NGF-induced phosphorylation of Akt (∼20% of control) and Erk1/2 to a lesser extent (∼60% of control; [Figure 7, A--C](#F7){ref-type="fig"}). Thus NHE5 knockdown and bafilomycin treatment commonly have a greater effect on the phosphorylation of Akt than the phosphorylation of Erk1/2 in response to NGF stimulation. Of interest, 1-h bafilomycin treatment, a condition that did not affect TrkA cell-surface abundance, reduced Akt phosphorylation but not Erk1/2 phosphorylation ([Figure 7, D--F](#F7){ref-type="fig"}).

![NHE5 knockdown affects NGF signaling. (A--D) Control PC12, shNHE5, and shNHE1 cells were serum starved overnight and then treated with 50 ng/ml NGF for the indicated times. The amounts of phosphorylated and total Akt and Erk1/2 were detected by Western blot (A and B, respectively). Representative Western blots are shown. The experiments were repeated three times, and the intensities of the bands were determined by densitometry. The relative levels of phospho-Akt (C) and phospho-Erk1/2 (D) are expressed as means ± SEM.](3435fig6){#F6}

![Bafilomycin A1 treatment affects NGF-TrkA signaling. Serum-starved PC12 cells were incubated in the absence (--) or presence (+) of 250 nM bafilomycin A1 for 6 h (A) or 1 h (D), and cells were stimulated with NGF (50 ng/ml) for the indicated periods. Whole-cell lysates (5 μg of protein) were subjected to SDS--PAGE and probed with anti--phospho-Akt, anti--phospho-Erk1/2, and anti--β-tubulin antibodies. Levels of phospho-Akt (B, E) and phospho-Erk1/2 (C, F) were quantified by densitometry and expressed as relative values to these observed at 5 min of NGF treatment in bafilomycin A1--untreated cells. Representative Western blots are shown in A and D. Densitometric data summarize three independent experiments and are presented as mean ± SEM. \**p* \< 0.05, \*\**p* \< 0.01 (paired Student\'s *t* test).](3435fig7){#F7}

NHE5 and neurite outgrowth
--------------------------

Having shown that NHE5, a significant endosomal acidifier in PC12 cells, influences the cell-surface abundance of TrkA and the downstream signaling of NGF-TrkA, we postulated that NHE5 might modulate NGF-induced neurite outgrowth. Control PC12 cells and PC12 cells expressing shNHE5 or shNHE1 were treated with NGF (50 ng/ml) for 72 h, followed by fixation and cytochemical visualization of actin and tubulin as a reliable read-out of cellular morphology. After NGF treatment, cells were examined for the presence or absence of neurite extensions of at least 15 μm in length emanating from the cell body ([@B80]). Compared to control cells, in which nearly 50% of the cells extended neurites, only ∼20% of shNHE5 cells formed neurites ([Figure 8, A and C](#F8){ref-type="fig"}). Moreover, the shNHE5 cells that did form neurites exhibited a significant reduction in total neurite number and length compared with the control cells ([Figure 8, B, D, and E](#F8){ref-type="fig"}). This reduction in neurite outgrowth was seen in multiple shNHE5 clones using three independent shRNA constructs (Supplemental Figure S3). Of interest, shNHE1 cells showed a small but significant increase in the number of cells forming neurites ([Figure 8, A and C](#F8){ref-type="fig"}), a trend opposite to that observed in shNHE5 cells. However, in shNHE1 cells that did form neurites, the mean total neurite number and length were significantly reduced ([Figure 8, A--D](#F8){ref-type="fig"}), in agreement with our previous study showing that pharmacological inhibition or genetic ablation of NHE1 adversely affect neurite elongation and branching ([@B80]). Thus, whereas knockdown of either NHE5 or NHE1 led to reductions in neurite number and length in cells that actually formed neurites, only knockdown of NHE5 impaired the cell\'s ability to differentiate in response to NGF treatment, as evidenced by the reduced number of cells with any neurite formation ([Figure 8C](#F8){ref-type="fig"}). To further investigate the specificity of the effects of shRNA, we generated double stable cells expressing both shNHE5 and hemagglutinin (HA)-tagged human NHE5 (NHE5~36HA~), which has a sequence different from that of rat NHE5 and is resistant to shNHE5 ([@B22]). The defective neurite morphology observed in shNHE5 cells was partially rescued in the double stable cells ([Figure 9, A--D](#F9){ref-type="fig"}). We next tested whether heterologously expressed NHE5 can rescue the defective NGF-induced signaling observed in shNHE5 cells. As shown in [Figure 9, E--G](#F9){ref-type="fig"}, NHE5 expression significantly increased phosphorylation of Akt and Erk1/2 in response to NGF stimulation. Finally, we transiently transfected shNHE5 into rat cortical neurons in primary culture and examined the effect on neurite formation. As shown in [Figure 10, A--C](#F10){ref-type="fig"}, both neurite number and length were slightly but significantly reduced as a result of shNHE5 expression. Although TrkA may be expressed in cultured cortical neurons, depending on culture conditions ([@B17]), TrkB is the predominant Trk receptor in cortex ([@B8]; [@B40]). Thus it will be important to test the effect of NHE5 on TrkB trafficking behavior and signaling.

![NHE5 modulates NGF-induced neurite growth in PC12 cells. (A, B) Control PC12 cells or PC12 cells stably expressing NHE5 shRNA (shNHE5) or NHE1 shRNA (shNHE1) were treated with 50 ng/ml NGF for 72 h to induce differentiation. Cells were labeled to visualize actin (green) and tubulin (red). Scale bars, 100 μm (A), 40 μm (B). (C) The percentage of cells in the population that formed at least one neurite ≥15 μm in length. In all cases *N* = 1700--1800 cells; error bars represent SEM; \*\**p* \< 0.01 (Student\'s *t* test) for difference from control cells. (D, E) Mean total neurite number (D) and length (E) in individual cells that had clearly differentiated (at least one neurite ≥15 μm in length). Under each condition *N* ≥ 80 cells.](3435fig8){#F8}

![Stable expression of NHE5~36HA~ reverses phenotypes of NHE5-deficient PC12 cells. (A) NGF-induced neurite outgrowth phenotype of shNHE5 cells stably expressing control vector or shRNA-resistant, HA-tagged human NHE5 (NHE5~36HA~). Anti-HA antibody (red) and fluorescently labeled phalloidin (green) were used to visualize F-actin and NHE5, respectively. Scale bar, 50 μm. The percentage of cells with at least one neurite extension (B), mean total neurite number (C), and length (D) in individual cells that had clearly differentiated (at least one neurite ≥15 μm in length). *N* ≥ 150 cells in each cell type per experiment; error bars represent SEM of *n* = 3 experiments; \**p* \< 0.05 (paired Student\'s *t* test) for difference from control cells. (E, F) shNHE5 cells stably expressing control vector or shRNA-resistant, HA-tagged human NHE5 (NHE5~36HA~) were serum starved overnight and then treated with 50 ng/ml NGF for the indicated times. The amounts of phosphorylated and total Akt and Erk1/2 were detected by Western blot. (E) Representative Western blots. The experiments were repeated three times, and the intensities of the bands were determined by densitometry. The relative levels of phospho-Akt (F) and phospho-Erk1/2 (G) are expressed as means ± SEM.](3435fig9){#F9}

![NHE5 participates in neurite growth in primary cortical neurons. (A--C) Primary rat cortical neurons (E18) were transfected with control plasmid or plasmid encoding shRNA against NHE5, both of which also express GFP. Transfected neurons were imaged by confocal microscopy at 4 d in vitro. (A) Two examples of each transfection. Scale bar, 25 μm. Total neurite number (B) and cumulative length (C) per cell. *N* = 34 control and 38 shNHE5 cells. Error bars represent SEM. \**p* \< 0.05, \*\**p* \< 0.01, by paired Student\'s *t* test.](3435fig10){#F10}

DISCUSSION
==========

Endosomes are functionally and morphologically heterogeneous organelles, and certain types of cells, such as neurons and epithelial cells, possess more complex endosomal systems than those in fibroblasts ([@B100]; [@B32]; [@B101]; [@B41]). In addition, recycling endosomal pH varies among different types of cells. For example, Madin--Darby canine kidney cells, a widely used model for polarized epithelial cells, have more acidic recycling endosomal compartments than those in Chinese hamster ovary cells ([@B30]; [@B99]), although the underlying mechanisms remain to be elucidated. In the present study, we identified the neuron-enriched ion transporter NHE5 as an endosomal pH regulator and showed that NHE5 knockdown diminishes cell-surface targeting of TrkA and impairs NGF signaling and neurite extension. Recycling endosomal pH in PC12 cells (pH = ∼6.20) is found to be more acidic than the previously reported value in Chinese hamster ovary cells (pH ≈ 6.5), which do not express NHE5 ([@B70]). Recycling endosomal pH in PC12 cells stably expressing shRNA for NHE5 (shNHE5 cells; pH ≈ 6.48) was close to the value observed in Chinese hamster ovary cells, and treatment of shNHE5 cells with a V-ATPase inhibitor further alkalinized recycling endosomes. Moreover, preliminary findings suggest that NHE-deficient Chinese hamster ovary mutant AP-1 cells have a recycling endosomal pH of 6.63 ± 0.05 (*N* = 263, mean ± SEM), close to the value (pH = 6.73) previously reported by [@B25]). Intriguingly, AP-1 cells stably expressing human NHE5 exhibited recycling endosomal pH of 6.33 ± 0.03 (*N* = 268, mean ± SEM), close to that observed in PC12 cells (Y.N. and G.H.D., unpublished data). Although we have to be cautious about the interpretation of these data (in light of the nonphysiological nature of the AP-1 cell experimental system, ambient expression levels of heterologously expressed NHE5, and its potential mislocalization), these findings obtained under the same conditions using the pH-sensitive fluorescent transferrin probe support the possibility that NHE5 and V-ATPase are the two separate physiological mechanisms that acidify recycling endosomes. NHE5 is responsible for endosomal acidification of PC12 cells and contributes to the establishment of a more acidic endosomal pH in PC12 than in Chinese hamster ovary cells. To our knowledge, this is the first molecule identified as a PC12 cell--specific endosomal acidifier. Treatment with the V-ATPase inhibitor bafilomycin also diminished the cell-surface targeting of TrkA and suppressed NGF-induced TrkA signaling in PC12 cells. Furthermore, [@B3]) showed that the protonophoric drug monensin leads to the intracellular accumulation of TrkA, a phenotype similar to that observed after depletion of NHE5 or bafilomycin treatment. These results collectively suggest that endosomal pH homeostasis by NHE5 plays a key role in the proper targeting of TrkA. Endosomal lumens are originally continuous with the extracellular space when vesicles are formed on the plasma membrane. In this regard, it is interesting that extracellular acidification has been suggested to increase the cell-surface targeting of TrkA ([@B11]).

We showed that perturbation of endosomal pH by NHE5 knockdown affects the cell-surface targeting of TrkA but not that of the Na^+^/K^+^-ATPase α-subunit (NKA). Our finding that depletion of NHE5 does not influence the internalization rate of TrkA is consistent with a previous study indicating that perturbation of endosomal pH does not affect retrograde NGF signaling or NGF-TrkA binding affinity in endosomes ([@B38]). Moreover, reversible biotinylation experiments suggested that the rate of TrkA targeting from recycling endosomes to the plasma membrane is impaired in NHE5-knockdown cells. These results indicate that impaired anterograde trafficking of TrkA via the recycling pathway primarily accounts for diminished signaling and defective neurite formation in NHE5-knockdown PC12 cells. A remarkable diversity of receptor recycling has been reported, and some integral membrane proteins follow recycling pathways distinct from that of transferrin receptors, a well-recognized marker for the bulk recycling pathway. Recent studies have started to reveal some mechanisms for cargo-specific recycling. For example, ligand-induced recycling of β2-adrenergic receptors, but not δ-opioid receptors, is facilitated by actin-stabilized endosomal tubules ([@B71]). More recently, an unbiased screening identified β integrins as cargoes whose recycling is facilitated by the FERM-like domain--containing sorting nexin SNX17 ([@B84]). We propose that endosomal pH is a novel regulatory factor for cargo-specific non--bulk recycling pathways. Previous studies showed that bafilomycin treatment markedly decreases the exit rate of TfnR from recycling endosomes to the plasma membrane in Chinese hamster ovary cells ([@B70]). However, we were not able to discern any effect of bafilomycin, nor were we able to see reproducible effects of NHE5 knockdown on cell-surface targeting of TfnR in PC12 cells. It has been reported that iron homeostasis is greatly influenced when yeast ([@B20]) and mammalian cells ([@B86]) are treated with bafilomycin. In addition, TfnR expression in some mammalian cell lines is up-regulated by treatment with bafilomycin ([@B86]). Thus we cannot completely rule out the possibility that endosomal pH affects TfnR trafficking in PC12 cells, an effect that might have been masked by unknown compensatory mechanisms under our experimental conditions. An alternative possibility is that cell type--specific targeting mechanisms contribute to TfnR targeting ([@B16]; [@B95]), and endosomal pH--dependent targeting may occur in a cell type--dependent manner. Careful follow-up studies are needed to resolve these issues.

Reduced cell-surface abundance of TrkA as a result of NHE5 depletion or pharmacological inhibition of V-ATPase should diminish NGF-induced phosphorylation of Akt and Erk to a similar extent. In fact, the maximum phosphorylation levels of Erk were reduced and the time after NGF treatment required to reach the maximum phosphorylation level was delayed as a consequence of NHE5 knockdown or V-ATPase inhibition. Unexpectedly, however, NGF-induced phosphorylation of Akt was more severely impaired than Erk phosphorylation. Most intriguingly, 1-h bafilomycin treatment, the condition that did not noticeably affect TrkA cell-surface abundance or Erk-phosphorylation, significantly decreased NGF-induced Akt phosphorylation. These results raise the interesting possibility that endosomal pH influences Akt phosphorylation in addition to TrkA trafficking. Phosphoinositide 3-kinase (PI3K)--Akt signaling occurs in endosomes in various cell types ([@B31]; [@B76]; [@B91]; [@B98]; [@B29]; [@B65]), including NGF-treated PC12 cells ([@B50]; [@B96]), and endosomal Akt signaling contributes to persistent NGF-TrkA signaling after the ligand--receptor complex is endocytosed ([@B38]). Recruitment of not only class II and class III PI3Ks, whose association with endosomes is well recognized, but also class I PI3K to endosomes and their possible activation therein has been suggested ([@B94]). Genetic studies in *Drosophila* and *Caenorhabditis elegans* suggest the possible involvement of receptor tyrosine kinases in class II PI3K signaling. Although much less is known about the role of receptor tyrosine kinases in class III PI3K signaling, there is evidence that class III PI3Ks are regulated by G protein--coupled receptors ([@B81]), indicating that class III PI3Ks may be activated by extracellular stimuli. Mounting evidence points to the possibility that endosomal membranes provide a location for signaling ([@B62]; [@B63]; [@B73]; [@B77]; [@B69]). The small endosomal lumen may define a discrete microenvironment segregated from the cytosol and regulate protein--protein and/or protein--lipid interactions required for signaling. It is interesting to speculate that endosomal pH might coordinate PI3K-Akt signaling by modulating the protonation and charge status of the signaling components. Early endosomes, including the Rab5-positive compartment and EEA1-positive fraction, are well documented as a potential location where intrinsic signaling arises ([@B31]; [@B79]; [@B83]). Recent studies reveal the involvement of late endosomes/lysosomes in endosomal signaling ([@B26]; [@B74]; [@B90]; [@B103]; [@B23]; [@B43]). We propose a model in which signal is generated and amplified in endocytic recycling compartments in a pH-dependent manner.

A prolonged incubation with bafilomycin for 5--6 h was needed to achieve an equivalent effect on TrkA targeting as NHE5 knockdown, implicating the possible involvement of additional factor(s). A recent genome-wide screening of a shRNA library identified V-ATPase subunits as essential molecules for clathrin formation during endocytosis ([@B46]). Intriguingly, however, prolonged bafilomycin treatment for up to 24 h was needed to elicit a similar effect on clathrin formation. The authors hypothesized that the constant delivery of membrane components (e.g., cholesterol) by endocytic recycling is required for clathrin formation and that the proper acidic endosomal pH is required for mobilizing membrane components. Similarly, membrane lipids or proteins supplied from other organelles in the endocytic recycling loop may be gradually depleted upon V-ATPase inhibition, and this in turn may slow down anterograde trafficking of TrkA. It is also of note that the action of NHE5 is more restricted to recycling endosomes, whereas inhibition of V-ATPases should have a broader effect on virtually all acidic organelles. If spatially restricted neutralization of recycling endosomes is important, V-ATPase inhibition may not elicit as strong an effect as NHE5 knockdown. To address these possibilities and uncover the underlying mechanism(s), it will be important to deplete V-ATPase subunit genes and examine their effects on TrkA trafficking.

An NHE1 gene defect is responsible for slow-wave epilepsy in mutant mice ([@B18]). We previously showed that NHE1 is targeted to growth cones and alkalinizes the cytosol during NGF-induced differentiation of PC12 cells ([@B80]). More recent work showed that NHE1 is associated with axonal termini and growth cones and suggested that NHE1 regulates axonal survival of Purkinje cells ([@B52]). NHE1 and NHE5 appear to regulate neuronal differentiation via different mechanisms. First, in contrast to the proposed axonal function of NHE1 ([@B52]), a recent immunohistochemical study suggested that NHE5 is predominantly localized to somatodendritic areas ([@B54]). Although we cannot exclude the possible involvement of NHE5 in axonal functions, NHE1 and NHE5 may be targeted to distinct neuronal domains and play different roles, a situation analogous to basolaterally associated NHE1 and apically targeted NHE3 in epithelia cells ([@B24]). Second, whereas NHE1 suppression also influences NGF-induced neurite outgrowth, the morphological features of NHE1-knockdown cells are different from those of NHE5-knockdown cells ([Figure 8](#F8){ref-type="fig"}). NHE1 regulates cytoskeletal remodeling by cofilin and cortactin ([@B28]; [@B55]), actin-binding proteins that play a central role in neurite extension ([@B19]; [@B53]; [@B9]), and, therefore, impaired actin cytoskeleton remodeling may contribute to the neurite phenotype of NHE1-knockdown PC12 cells. NHE5 may play a prominent role in initiating neurite formation and polarity establishment, whereas NHE1 may promote neurite extension and branching.

The precise identification of molecular mechanisms underlying extracellular/endosomal luminal pH-dependent TrkA trafficking awaits future studies. However, there are several candidates. A small GTPase, Arf6, and its GDP/GTP exchange factor, ARNO, are recruited to early endosomal membranes by direct interaction with V-ATPase subunits in a luminal acidification--dependent manner ([@B42]). We previously proposed a model in which secretory carrier membrane proteins, a group of integral membrane proteins that shuttle among multiple organelles, guide NHE5 to the Arf6-dependent recycling circuit ([@B21]). Arf6 has been suggested to target endosomally activated Rac1, a key molecule that controls NGF-induced axonal growth and growth cone guidance ([@B72]), to a specialized plasma membrane domain ([@B67]). It is interesting to postulate that NHE5 and V-ATPase may show close association on endosomal membranes and that their functional collaboration may activates Arf6, which in turn targets signaling molecules, including Rac1, to a membrane subdomain that induces neurite formation at this location. Indeed, endocytic recycling of Met (hepatocyte growth factor receptor; [@B44]) and vascular endothelial growth factor receptors ([@B64]) has been suggested to be crucial for efficient signaling and Arf6 to be a key molecule in this process ([@B68]). In addition, a recent study showed that a pH-dependent mechanism governs recycling of galectin-3 and the low-affinity neurotrophin receptor p75 at the apical membrane of polarized epithelial cells ([@B85]). The pH-sensitive recycling of unique groups of proteins and lipids may play a crucial part in cell polarity establishment.

MATERIALS AND METHODS
=====================

Cell lines
----------

PC12 cells were transfected with pRNAT-H1 vectors (GenScript, Piscataway, NJ) containing shRNA sequences targeting NHE5 or by pRNAT-U6 vectors (GenScript) containing shRNA sequences targeting NHE1 by calcium phosphate method, and stable clones showing reduced protein expression were isolated as described previously ([@B22]). Stable clones were maintained in the presence of 200 μg/ml G418 or 100 μg/ml hygromycin, and low--passage number cells were used for all experiments. A snapshot Western blot was performed to verify the suppression of the protein before experiments. PC12-based cell lines were grown in DMEM containing 5% fetal bovine serum (FBS) and 10% heat-inactivated horse serum.

Antibodies and biochemical reagents
-----------------------------------

Rabbit polyclonal anti-NHE5 antibodies were raised and characterized as previously described ([@B22]). The following additional primary antibodies were used: mouse monoclonal anti-NHE1, anti-EEA1, and anti-Rab11 (BD Biosciences, San Jose, CA), mouse monoclonal anti-Na^+^/K^+^ ATPase α-subunit (Developmental Studies Hybridoma Bank, Iowa City, IA), mouse monoclonal anti--transferrin receptor (Zymed, San Francisco, CA), rabbit polyclonal (C-14) and mouse monoclonal (B-3) anti-TrkA (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit polyclonal anti-Erk1/2 (Biosource, Camarillo, CA), and rabbit polyclonal anti--phospho-Erk, anti-Akt, and anti--phospho-Akt (Cell Signaling, Danvers, MA). The following secondary antibodies were used: Alexa Fluor 488--conjugated goat anti-mouse or Alexa Fluor 568--conjugated goat anti-rabbit (Molecular Probes, Eugene, OR) and horseradish peroxidase--conjugated goat anti-rabbit and goat anti-mouse secondary antibodies (Jackson ImmunoResearch, West Grove, PA). All biochemical reagents were of analytical grade or higher and obtained from Sigma-Aldrich (St. Louis, MO) unless otherwise indicated. Monomeric red fluorescent protein (mRFP)--tagged human Rab5 cDNA (plasmid \#14437) and mRFP-tagged dog Rab7 (plasmid \#14436) were obtained from Addgene (Cambridge, MA), and the inserts were subcloned into the pECFP or pmCherry vector.

Immunofluorescence confocal microscopy
--------------------------------------

PC12-based cell lines were fixed for 10 min at room temperature with 4% paraformaldehyde in phosphate-buffered saline (PBS), permeabilized with 0.1% Triton X-100 in PBS for 10 min at room temperature or fixed for 10 min by prechilled methanol--acetone (80--20% \[vol/vol\], −20°C) with no permeabilization, blocked with PBS containing 10% normal goat serum for 30 min, and then incubated with primary antibody in PBS containing 1% goat serum overnight at 4°C. After washing, coverslips were incubated with fluorescently labeled secondary antibodies at room temperature for 1 h. After additional washes, they were then mounted onto glass slides with Prolong Gold antifade reagent (Life Technologies, Carlsbad, CA). Confocal images were obtained with the 100×/numerical aperture 1.4 UPlanApo objective of an Olympus FV1000 (Olympus, Tokyo, Japan).

Neurite growth measurement
--------------------------

Neurite growth was measured as described previously ([@B80]). In brief, PC12-based cell lines were plated onto collagen-coated glass coverslips and grown for 72 h in DMEM containing 1% FBS, 2% horse serum, and 50 ng/ml NGF (Cedarlane Laboratories, Burlington, Canada). After 72 h of NGF treatment, tubulins and actins were visualized by immunofluorescence microscopy with anti-tubulin antibody and fluorescently labeled phalloidin, respectively. Randomly selected fields of cells were imaged by confocal or fluorescence microscopy using a 10× magnification objective, and the number and length of neurites were measured using ImageJ software (National Institutes of Health, Bethesda, MD). All cells in a field were counted, and cells with at least one neurite extension \>15 μm in length were scored as cells with neurites. For neurite length and number calculation, only cells with at least one primary neurite \>15 μm in length were imaged and included in analyses. The number and cumulative length of primary neurites (extensions from the cell body of at least 10 μm in length) and secondary neurites (second- and higher-order neurites at least 5 μm in length) were measured. Data are presented as the mean total number of neurites per cell (primary and secondary neurites) or as the total length of neurites from \>80 cells per condition. For rescue experiments, NHE5-knockdown cell lines were transfected with HA-tagged human NHE5, and clones stably expressing human NHE5 were used.

NGF signaling
-------------

Subconfluent PC12-based cell lines were serum starved overnight, treated with NGF (50 ng/ml) in serum-free media for the times indicated, and then lysed using 1% NP-40 in PBS containing protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN). Equal amounts of protein for each condition were resolved by SDS--PAGE, and total or phosphorylated amounts of specific proteins were assessed by Western blot.

Cell-surface biotinylation
--------------------------

Subconfluent PC12-based cell lines were serum starved overnight and then treated with 50 ng/ml NGF or 250 nM bafilomycin A1 (LC Laboratories, Woburn, MA) in serum-free media for the times indicated. Cell-surface biotinylation was carried out as described previously ([@B51]). In brief, cells were incubated with the membrane-impermeable, protein-reactive biotinylation reagent *N*-hydroxysulfosuccinimidyl-SS-biotin (0.5 mg/ml; Thermo Scientific, Waltham, MA) in PBS containing 0.1 mM CaCl~2~ and 1 mM MgCl~2~ (PBSCM) for 30 min at 4°C, and unreacted biotinylation reagent was quenched with 20 mM glycine in PBSCM, two times for 7 min each. Cells were then lysed in 1% NP-40 in PBS containing protease inhibitor cocktail. Equal amounts of protein were incubated overnight at 4°C with NeutrAvidin-conjugated agarose beads (Thermo Scientific). After washing of the beads with ice-cold lysis buffer, biotinylated proteins were eluted using SDS sample buffer containing 100 mM dithiothreitol, and surface-labeled proteins were resolved by SDS--PAGE and detected by Western blot. Five percent of the total lysate not subjected to NeutrAvidin beads was also resolved as a loading control.

Endosomal pH measurement
------------------------

Cells were grown on collagen-coated glass-bottom dishes, serum starved for 4 h, and then incubated in Na^+^-saline (130 mM NaCl, 5 mM KCl, 1 mM MgCl~2~, 2 mM CaCl~2~, 5 mM glucose, 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid \[HEPES\]--NaOH, pH 7.4) containing 75 μg/ml fluorescein-conjugated transferrin (Molecular Probes) and 25 μg/ml Alexa Fluor 568--conjugated transferrin (Molecular Probes) for 1 h at 37°C. Cells were then rinsed three times with Na^+^-saline and then imaged by confocal microscopy for up to 10 min in a temperature-controlled chamber at 37°C. Fluorescein was imaged by excitation with a 488-nm laser, and Alexa Fluor 568 was imaged using a 546-nm laser. Fluorescein is pH sensitive, whereas Alexa Fluor 568 is pH insensitive, and thus by imaging the two fluorophores together, we were able to perform ratiometric measurements of endosomal pH ([@B25]; [@B30]; [@B12]; [@B66]; [@B22]). To convert the fluorescein/Alexa Fluor 568 fluorescence ratios to pH, we imaged fluorescein- or Alexa-conjugated transferrin-loaded cells under pH-clamp conditions (high K^+^, 10 μM nigericin, pH 6.0--7.0). In some experiments transferrin-loaded cells were imaged after treatment with the V-ATPase inhibitor bafilomycin (250--500 nM) to cause endosomal alkalinization. For early endosomal pH measurement experiments, cells were treated with the mixture of fluorescein- and Alexa Fluor 568--conjugated Tfn at 4°C for 30 min, rinsed with prechilled serum-free media, and subjected to chase incubation at 22°C for up to 15 min. Confocal images were obtained with the 100×/numerical aperture 1.4 UPlanApo objective of an Olympus FV1000 or a III-Zeiss spinning disk confocal microscope.

NHE activity assay
------------------

NHE activity was measured as described previously ([@B21]). In brief, PC12 cells were loaded with 2 μM BCECF acetoxymethyl ester in HEPES-buffered saline (HBS; 130 mM NaCl, 5 mM KCl, 1 mM MgCl~2~, 2 mM CaCl~2~, 5 mM glucose, 20 mM HEPES-NaOH, pH 7.4) for 10 min at room temperature. Coverslips with cells attached were then mounted in a temperature-controlled recording chamber filled with HBS, placed on the microscope stage, and superfused at 2 ml/min with HBS at 34°C throughout an experiment. The dual--excitation ratio method was used to estimate pH*~i~* using a fluorescence ratio imaging system (Atto Biosciences, Rockville, MD), and the high--\[K^+^\]/nigericin technique was used to convert background-corrected BCECF emission intensity ratios into pH*~i~* values. Intracellular acid loads were imposed by exposing the cells for 2 min to NH~4~^+^--choline chloride solution, followed by washout with choline chloride solution. Na^+^/H^+^ exchange was activated by a return to HBS in the absence or presence of the NHE1-specific antagonist cariporide (10 μM).

Neuronal cell culture and neurite growth measurement
----------------------------------------------------

Cortex from E18 rat was prepared as previously described ([@B102]). Dissociated neurons were transfected with control or NHE5 shRNA plasmid (contains a green fluorescent protein \[GFP\] expression cassette) by nucleoporation using a rat neuron nucleoporation kit (Lonza, Cologne, Germany) before plating. Electroporated neurons were plated at a density of 250 cells/mm^2^ on poly-[l]{.smallcaps}-lysine--coated coverslips. Neurons were grown for 4 d in vitro in a humidified incubator under 5% CO~2~ in neurobasal medium supplemented with 5% horse serum, 1% penicillin/streptomycin, 1% GlutaMAX, and 2% B27 supplement (Life Technologies). Neurons were fixed in 4% paraformaldehyde in PBS for 10 min and mounted on glass slides, and GFP-positive cells were imaged by confocal fluorescence microscopy. Neurite number and length were measured as previously described ([@B80]) using ImageJ software.
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